| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.41B | — | +20.0% |
| Cost of Revenue | $722.7M | — | +22.3% |
| Gross Profit | $684.2M | — | +17.7% |
| R&D Expense | $262.2M | — | +3.1% |
| SG&A Expense | $102.5M | — | +11.4% |
| Operating Income | $107.7M | — | +366.5% |
| Pre-tax Income | $102.2M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $542.0M | -20.6% | +16.0% |
| Accounts Receivable | $710.5M | +11.6% | +23.0% |
| Current Assets | $3.45B | -3.6% | -0.6% |
| Total Assets | $9.58B | -2.0% | -2.4% |
| Current Liabilities | $740.3M | -16.5% | +2.0% |
| Long-term Debt |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $153.2M | — | -19.8% |
| Investing Cash Flow | -$41.2M | — | -115.2% |
| Financing Cash Flow | -$252.6M | — | -100.8% |
| +284.6% |
| Income Tax | $12.1M | — | +84.1% |
| Net Income | $90.1M | — | +350.3% |
| EPS (Basic) | $0.59 | — | +353.8% |
| EPS (Diluted) | $0.57 | — | +375.0% |
| $992.7M |
| +0.0% |
| +0.2% |
| Total Liabilities | $1.79B | -8.0% | -1.0% |
| Stockholders' Equity | $7.78B | -0.5% | -2.8% |